Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Immunol Invest ; 40(2): 150-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21062235

RESUMO

The purpose of this study is to determine the expression of CD14 as a marker of the innate immunity in hypertrophic adenoids and tonsils. Twenty-four pediatric patients (age <12 years) with obstructive adenotonsillar hypertrophy, confirmed by sleep study were included in this study. Intensity and expression of positive CD14 infiltrating cells was assessed by immunohistochemistry in specific histologic areas. In tonsils, CD14 immunoreactivity was demonstrated in intraepithelial lymphocytes located in the basal layer of the stratified squamous mucoepithelium. CD14 expression was significantly higher in mucosal layers and inter-follicular areas of tonsils than adenoid tissues [(p < 0.001), (p = 0.021), respectively]. CD14 expression was significantly higher in the submucosal layers of adenoids than tonsil tissues (p = 0.002). Hypertrophic adenoids and tonsils from children with OSA are prominent sites of innate defense, with over expression of CD14. The enhanced expressions of CD14 cells in adenoids and tonsils may be an important factor for the development and persistence of adenoids and tonsils enlargement causing OSA in children. CD14 expression in adenoids and tonsils illustrates an important immunological sentinel function of the innate immunity of the upper airway.


Assuntos
Tonsila Faríngea/patologia , Imunidade Inata/imunologia , Receptores de Lipopolissacarídeos/metabolismo , Tonsila Palatina/patologia , Receptores Imunológicos/genética , Receptores Imunológicos/metabolismo , Tonsila Faríngea/imunologia , Criança , Pré-Escolar , Feminino , Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Humanos , Hipertrofia/patologia , Lactente , Linfócitos/imunologia , Linfócitos/patologia , Masculino , Tonsila Palatina/imunologia , Plasmócitos/imunologia , Plasmócitos/patologia , Apneia Obstrutiva do Sono/imunologia , Apneia Obstrutiva do Sono/patologia
2.
Ann Otol Rhinol Laryngol ; 118(5): 374-81, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19548388

RESUMO

OBJECTIVES: The purpose of this study was to define the clinicopathologic features and outcome of the oncocytic variant of papillary thyroid carcinoma (OVPTC) with a review of the literature. METHODS: Twenty-three patients with OVPTC over a 10-year period were studied. Demographic, clinical, and histopathologic features and outcome data were analyzed retrospectively. RESULTS: Seventeen women and 6 men, ages ranging from 20 to 76 years (95% confidence interval, 43.0 to 54.48), were studied. Cervical lymph node involvement was found in 43.4% of the patients. Most of the recurrences were associated with thyroid masses greater than 2 cm in diameter. Evaluation of the overall survival data by the Kaplan-Meier method revealed that most recurrences took place earlier than 30 months, and the majority of patients (74%) were well, with no evidence of disease, up to 78 months after the last treatment. All of the OVPTC cases presented as nonencapsulated tumors, and 78.2% demonstrated extrathyroid stromal invasion. CONCLUSIONS: OVPTC is a unique variant of papillary thyroid carcinoma that has distinctive clinicopathologic features. Since OVPTC is often associated with local invasion and may involve cervical lymph nodes, it may require more extensive surgery than classic papillary thyroid carcinoma.


Assuntos
Adenoma Oxífilo/patologia , Neoplasias da Glândula Tireoide/patologia , Adenoma Oxífilo/mortalidade , Adenoma Oxífilo/cirurgia , Adulto , Idoso , Feminino , Humanos , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Recidiva Local de Neoplasia/epidemiologia , Estudos Retrospectivos , Neoplasias da Glândula Tireoide/mortalidade , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia , Fatores de Tempo , Adulto Jovem
3.
Audiol Neurootol ; 13(4): 231-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18259075

RESUMO

Sudden sensorineural hearing loss (SSNHL) is frequently classified as 'idiopathic' since the causative factor responsible for its onset is not identified in most cases. In the present study, we determined whether SSNHL is clinically associated with serum anti-heat shock protein-70 (anti-HSP70) and antiphospholipids (anti-PLs) autoantibodies and whether these autoantibodies have an impact on the prognosis of SSNHL. Sera from 63 patients with SSNHL were screened prospectively for the presence of anti-HSP70 and anti-PLs autoantibodies by an enzyme-linked immunosorbent assay test. Anti-PLs antibodies in this study consisted of anticardiolipin, and anti-beta(2)-glycoprotein-1 antibodies. Serum was assayed for anti-HSP70 IgG antibodies using recombinant human HSP70. Demographic, clinical, and audiometric variables were analyzed to find the possible role of serum autoantibodies in SSNHL patients. Sixteen patients (25.4%) had demonstrable anti-HSP70 antibodies in serum. Twenty-one patients (33.3%) showed a positive result for at least one isotype (IgM or IgG) of anti-PLs. In 19% of the patients, anti-HSP70 and anti-PLs antibodies were positive in two combinations. A statistically significant association was found between anti-HSP70 antibodies and the Siegel recovery grade subgroup. SSNHL patients who were positive for anti-HSP70 antibodies showed a significantly higher rate of complete recovery and incomplete but partial recovery than SSNHL patients without anti-HSP70 antibodies (p = 0.0496). Statistically significant association was found between total anticardiolipin, total anti-beta(2)-glycoprotein-1, total anti-PLs, and anti-PLs in combination with anti-HSP70 antibodies and age (p = 0.0229). The detection of autoantibodies to HSP70 and PLs offers a pliable explanation for the immune-mediated mechanism of SSNHL. The present study confirms and supports previous studies regarding the association between anti-HSP70 and anti-PLs antibodies with SSNHL, and is the first to identify a positive association between anti-HSP70 antibodies and a positive outcome of SSNHL. Further studies are necessary in order to identify and further clarify the immunologic role of the presence of autoantibodies and their impact on the prognosis of SSNHL.


Assuntos
Anticorpos Anticardiolipina/sangue , Autoanticorpos/sangue , Proteínas de Choque Térmico HSP70/imunologia , Perda Auditiva Súbita/imunologia , beta 2-Glicoproteína I/imunologia , Adolescente , Adulto , Idoso , Anticorpos Antifosfolipídeos/sangue , Audiometria de Tons Puros , Limiar Auditivo/fisiologia , Ensaio de Imunoadsorção Enzimática , Feminino , Seguimentos , Humanos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Prognóstico , Zumbido/imunologia
4.
J Leukoc Biol ; 82(5): 1095-105, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17675561

RESUMO

Adenoids are part of the MALT. In the present study, we analyzed cell surface markers and cytolytic activity of adenoidal NK (A-NK) cells and compared them with NK cells derived from blood of the same donors (B-NK). NK cells comprised 0.67% (0.4-1.2%) of the total lymphoid population isolated from adenoids. The majority (median=92%) of the A-NK cells was CD56(bright)CD16(-). A-NK cells were characterized by the increased expression of activation-induced receptors. NKp44 was detected on >60%, CD25 on >40%, and HLA-DR on >50% of freshly isolated A-NK cells. Functional assays indicated that the cytotoxic machinery of A-NK is intact, and sensitive target cells are killed via natural cytotoxicity receptors, such as NKG2D. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1; CD66) expression was up-regulated in 23% (median) of the A-NK cells by IL-2 activation but unchanged in B-NK cells. CEACAM1 inhibited the A-NK killing of target cells. CXCR4 was expressed on more than 40% A-NK cells prior to activation. Its ligand, CXCL12, was found in endothelial cells of the capillaries within the adenoid and in cells of the epithelial lining. In addition, A-NK cells migrated in vitro toward a gradient of CXCL12 in a dose-responsive manner, suggesting a role for this chemokine in A-NK cell recruitment and trafficking. We conclude that the A-NK cells are unique in that they display an activated-like phenotype and are different from their CD16(-) B-NK cell counterparts. This phenotype presumably reflects the chronic interaction of A-NK cells with antigens penetrating the body through the nasal route.


Assuntos
Tonsila Faríngea/metabolismo , Movimento Celular , Sobrevivência Celular , Células Matadoras Naturais/metabolismo , Tonsila Faríngea/imunologia , Tonsila Faríngea/patologia , Antígenos CD/metabolismo , Antígeno CD56/metabolismo , Moléculas de Adesão Celular/metabolismo , Quimiocina CXCL12/metabolismo , Criança , Citotoxicidade Imunológica , Endotélio Vascular/citologia , Endotélio Vascular/metabolismo , Proteínas Ligadas por GPI , Humanos , Interleucina-2/metabolismo , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/patologia , Subfamília K de Receptores Semelhantes a Lectina de Células NK , Receptor 2 Desencadeador da Citotoxicidade Natural , Fenótipo , Receptores de IgG/metabolismo , Receptores Imunológicos/metabolismo , Receptores de Células Matadoras Naturais
5.
Acta Otolaryngol ; 126(9): 1005-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16864503

RESUMO

Osteomas are benign, slow growing tumors of bone that occur almost exclusively in the craniofacial region. They are uncommon in the temporal bone. Surgical excision is indicated in symptomatic cases. An osteoma arising from the lateral semicircular canal growing into the mastoid cavity is extremely rare and usually discovered on routine radiography. We present a case of osteoma arising from the lateral semicircular canal growing into the mastoid cavity, followed by a discussion of the etiology, presentation, and management of osteomas.


Assuntos
Neoplasias Ósseas/diagnóstico , Osteoma/diagnóstico , Canais Semicirculares/patologia , Neoplasias Ósseas/cirurgia , Feminino , Humanos , Processo Mastoide/patologia , Processo Mastoide/cirurgia , Pessoa de Meia-Idade , Invasividade Neoplásica , Osteoma/cirurgia , Canais Semicirculares/cirurgia
6.
Ear Nose Throat J ; 89(8): 382-6, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20737377

RESUMO

Laryngeal vascular leiomyomas are uncommon benign tumors that seldom recur following complete excision. The choice of excision procedure-via direct laryngoscopy or an open approach-is dictated by tumor size, the expected amount of blood loss, and any comorbidities the patient may have. We report an unusual case of a recurrent laryngeal vascular leiomyoma in a 64-year-old woman who also had a concurrent parathyroid adenoma and a history of breast carcinoma. A surgical resection via an external approach along with laser resection of a small glottic component was needed.


Assuntos
Angiomioma/cirurgia , Neoplasias Laríngeas/cirurgia , Recidiva Local de Neoplasia/cirurgia , Adenoma/cirurgia , Angiomioma/complicações , Angiomioma/diagnóstico , Feminino , Humanos , Neoplasias Laríngeas/complicações , Neoplasias Laríngeas/diagnóstico , Laringoscopia , Laringe/patologia , Terapia a Laser , Imageamento por Ressonância Magnética , Prontuários Médicos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/diagnóstico , Neoplasias Primárias Múltiplas/cirurgia , Neoplasias das Paratireoides/cirurgia , Reoperação , Transtornos Respiratórios/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA